Skip to main content
Erschienen in: BMC Women's Health 1/2021

Open Access 01.12.2021 | Research

Impact of surgery on quality of life of Ugandan women with symptomatic pelvic organ prolapse: a prospective cohort study

verfasst von: Musa Kayondo, Dan Kabonge Kaye, Richard Migisha, Rodgers Tugume, Paul Kalyebara Kato, Henry Mark Lugobe, Verena Geissbüehler

Erschienen in: BMC Women's Health | Ausgabe 1/2021

Abstract

Background

Pelvic organ prolapse (POP) is a significant public health issue that negatively affects the Quality of Life (QOL) of women in both low and high-income countries. About 20% of women will undergo surgery for POP over their lifetime. However, there is a paucity of information on the effect of surgery on QOL especially in resource-limited settings. We therefore assessed the QOL among women with symptomatic POP living in rural southwestern Uganda and the impact of surgery on their quality of life.

Methods

We conducted a prospective cohort study among 120 women with symptomatic POP scheduled for surgery at the urogynecology unit of Mbarara Regional Referral Hospital. The QOL at baseline and at 1 year after surgery in the domains of physical performance, social interaction, emotional state, sexual life, sleep quality, personal hygiene and urinary bladder function was determined using a King’s Quality of Life questionnaire. A paired t-test was used to compare the difference in mean scores at baseline and at 1-year post-surgery.

Results

Of the 120 participants that were enrolled at baseline, 117(98%) completed the follow-up period of 1 year. The baseline QOL was poor. The domains with the poorest QOL were physical, social, sexual, emotional and sleep quality. The mean QOL scores in all the domains and the overall QOL significantly improved 1 year after surgery (p < 0.001). The overall QOL improved by 38.9% after surgery (p < 0.001).

Conclusions

The QOL was poor among women with symptomatic POP and surgery improved the QOL in all the domains of life. We recommend that surgery as an option for treatment of symptomatic POP should be scaled up to improve on the QOL of these women.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
POP
Pelvic organ prolapse
PFDs
Pelvic floor disorders
QOL
Quality of Life
POP-Q
Pelvic organ prolapse quantification
ICS
International Continence Society
USA
United States of America
MRRH
Mbarara Regional Referral Hospital
MUST
Mbarara University of Science and Technology
UNCST
Uganda National Council of Science and Technology

Background

Pelvic Organ Prolapse (POP) is defined as an anatomic support defect of the pelvic viscera resulting from the long-term failure of their supporting and suspension mechanisms [1]. This weakness in the supporting mechanisms leads to descent of the pelvic organs, including the bladder, uterus, rectum and or small intestines, into or outside of the vagina [2]. POP affects more than half of parous women over the age of 50 years worldwide [3]. Various risk factors for POP have been reported including childbirth, ageing, heavy manual labour and menopause [4].
POP affects many aspects of women’s life including physical, psychological, social interaction, sexual function and hygiene [5]. Women with POP present with a variety of symptoms including urinary, bowel, sexual, and psychological which greatly compromise their quality of life (QOL) [69]. In the advanced stages, POP presents with debilitating physical symptoms like difficulty in walking, sitting and squatting, which negatively impacts the daily economic activities of these women like farming eventually resulting in poverty [10, 11]. In addition, women with POP frequently report limitations to their sexual life such as: lack of sexual desire, arousal, orgasm, and pain during intercourse which ultimately leads to loss of sexual interest with some being abandoned by their husbands [5, 7, 1214]. A number of psychological and mental health problems have been reported among women with POP including emotional disturbances, depression, loss of self-esteem, lack of sleep, rejection and isolation [1518].
Therefore, symptomatic POP requires management which may be surgical or nonsurgical (conservative) to improve QOL. Conservative treatment options like pessaries, lifestyle change, and pelvic floor exercises have been shown to be effective as an alternative to surgery [1921]. However, pessaries are not readily available and hence their use by clinicians in treatment of symptomatic POP in this setting is low [22], leaving surgery as the main mode of management of symptomatic POP.
About 20% of women will undergo surgery for POP over their lifetime [23] with close to 200,000 POP surgeries being performed in the United States of America (USA) annually [24]. However, access to POP surgery in low income countries is very limited because it is expensive and the skilled personnel to perform the surgery are few [25]. Surgery for symptomatic POP has been shown to improve the QOL in high income countries [5, 13, 2628]. However, in low income countries including Uganda, the impact of surgery on QOL is rarely reported yet this evidence is important for advocacy in scaling up treatment for POP in these resource limited settings where women with POP face various challenges in accessing care [12].
Therefore, in this study we aimed to assess the quality of life among women with symptomatic POP in rural Southwestern Uganda before and after surgery in the seven life domains; physical, social interaction, psychological, sexual activity, personal hygiene, sleep and bladder function.

Methods

Study setting, design and study population

We conducted a prospective cohort study at the Urogynecology unit of Mbarara Regional Referral Hospital (MRRH) from December 1, 2018 to December 31, 2020, among women diagnosed with symptomatic pelvic organ prolapse (POP) scheduled for surgery. MRRH is a tertiary Hospital located in Mbarara district in Southwestern Uganda about 250 km from the capital city of Kampala. MRRH is the main referral hospital of the entire southwestern Uganda serving over 10 districts and also gets patients from the neighboring countries of Tanzania, Rwanda, Burundi and the Eastern Democratic Republic of Congo (DRC).

Data collection

Preoperative workup

The diagnosis of POP, clinical exam, staging of POP, and decision to do surgery was made by the urogynecology surgical team. Participants were diagnosed to have POP if they had any one of the following clinical findings: cystocele, urethrocele, cystourethrocele, uterine prolapse, vault prolapse, enterocele, or rectocele. Staging of POP was done using the Pelvic Organ Prolapse Quantification (POP-Q) system validated by the International Continence Society (ICS) into stages I, II, III and IV [29, 30].
An interviewer guided data capture tool was administered to collect information on the baseline characteristics of the study participants. These included: age, parity, education level, marital status, occupation, smoking, alcohol use, type and severity of the prolapse. Age in years was categorized according to reproductive age groups: 18–34 (early reproductive age group), 35–49 (late reproductive), 50–59 (peri-menopausal) and ≥ 60 (post-menopausal).
The participants had their quality of life (QOL) determined at enrolment prior to surgery. The QOL was determined using the King’s Health Questionnaire [31]. This questionnaire was validated to assess the QOL among women with urinary incontinence but we used it to assess QOL among women with POP in our study as a number of women with POP have been shown to have urinary incontinence [3234]. This interviewer-based questionnaire assesses seven QOL domains that include physical/daily roles performance, social interraction, sexual function, emotional/psychological state, personal hygiene, sleep quality and bladder function. A score (%) for each of the domains was calculated. Each life domain had a score ranging from 0 to 100%. The overall QOL for each participant was obtained as an average of the total scores in the seven domains. The higher the scores the poorer the QOL. Trained research assistants who included counsellors and nurses who were not part of the surgical team conducted the interviews and completed the King’s Heath Questionnaire.

Surgery for pelvic organ prolapse

The participants underwent surgery for the management of POP. Surgery was performed in those who had symptomatic POP stage II, III and IV and was dependent on the type of prolapse. The different surgical procedures that were performed include anterior colporrhapy for cystocele, posterior colporrhapy for rectocele, vaginal hysterectomy with vaginal vault suspension (sacrospinous ligament or uterosacral vault suspension) for uterine prolapse in those who had completed child bearing and did not want uterine sparing surgery, and bilateral sacrospinous vault suspension in those with recurrent vaginal vault prolapse. Cervicopexy was done for those with uterine prolapse that hadn’t completed child bearing or wanted uterine sparing surgery.

Postoperative follow up

After discharge, the participants were invited back to the hospital one year after surgery for a follow-up visit. Participants were contacted through a phone call one week prior to their scheduled postoperative visit. The purpose of the call was to remind the participants of their scheduled follow-up visit. Participants who could not be reached on phone were traced using the contacts of their next of kin. This was to minimize loss to follow-up. At this follow-up visit, the QOL one year after surgery was again assessed by the trained research assistants using the King’s Health Questionnaire.

Power calculation

A post-hoc power calculation was done where we assumed a sample size of 120, mean QOL score before surgery of 44.5 with a standard deviation of 20.9 and a mean QOL score after surgery of 8.0 with a standard deviation of 11.6. We therefore obtained a power of 100% to detect a difference in means. This sub study was part of a larger study to determine the recurrence rate of POP following surgery.

Statistical analysis

Data were entered into Redcap and exported to Stata 13 (StataCorp, LLP, College Station, TX, USA) for analysis. Categorical data were presented as frequencies (%). The mean QOL score and the 95% confidence intervals for each of the seven domains and the overall mean QOL at baseline and at 1 year after surgery were calculated. The overall mean QOL score before and at 1 year after surgery was compared as well as the mean scores in each of the domains. A paired t-test was used to determine if there was a significant difference in the means. A p value of < 0.05 was considered significant.

Ethical considerations

Ethical approvals were obtained from the Mbarara University of Science and Technology (MUST) Research Ethics Committee and the Uganda National Council for Science and Technology (UNCST) number HS368ES. Written informed consent was obtained from all the study participants or from their legally authorized representatives for those who couldn’t read or write. Confidentiality was observed during all the interviews. Personal identifiers such as name and in-patient number were not collected. The study participants were assigned study ID numbers.

Results

A total of 130 women with symptomatic POP scheduled for surgery were seen during the study period. Of these, 10 declined to consent and were not included in the study. We therefore enrolled a total of 120 participants into the study. The participants were followed up for 12 months post-surgery, with 117 completing the follow-up period giving a completion rate of 97.5%. The mean age of the study participants was 55 years (SD ± 15) with the majority (n = 46, 38.3%) aged ≥ 60 years, peasant farmers (n = 106, 88.3%) and had had five or more deliveries (n = 94, 78.3%) as shown in Table 1.
Table 1
Baseline participants’ characteristics
Characteristic
Description
Total (N = 120)
Frequency
Percentage
Age in years
18–34
7
5.8
35–49
35
29.2
50–59
32
26.7
 ≥ 60
46
38.3
Residence
Rural
115
95.8
Urban
5
4.2
Level of education
None
65
54.2
Primary
49
40.8
Secondary
4
3.3
Tertiary
2
1.7
Marital status
Married
59
49.2
Separated
12
10.0
Single
32
26.7
Widowed
17
14.2
Occupation
Peasant
106
88.3
Business
9
6.9
Others
8
6.7
Monthly incomeφ
 < 50 k
84
70.0
50–100 k
25
20.8
 > 100 k
11
9.2
Parity
0–4
26
21.7
 ≥ 5
94
78.3
History of smoking
No
82
68.3
Yes
38
31.7
Alcohol consumption
No
67
55.8
Yes
53
44.2
φIncome in Ugandan shillings; 1 k = 1000 shillings
The majority of the participants had uterine prolapse (n = 85, 70.8%) and the commonest stage of POP was stage III (n = 56, 46.7%) as shown in Table 2.
Table 2
Types and stages of POP among the study participants
Characteristic
Description
Total (N = 120)
Frequency
Percentage
Anterior vaginal wall prolapse
No
33
27.5
Yes
87
72.5
Posterior vaginal wall prolapse
No
88
73.3
Yes
32
26.7
Uterine prolapse
No
35
29.2
Yes
85
70.8
Post hysterectomy Vault prolapse
No
117
97.5
Yes
3
2.5
Enterocele
No
113
94.2
Yes
7
5.8
Pre-surgery POPQ stage
I
0
0.0
II
28
23.3
III
56
46.7
IV
36
30.0
The surgical procedures that were performed and the related complications are shown in Table 3. The most common procedure performed among the study participants was Vaginal hysterectomy with sacrospinous ligament vault fixation in 66 (55%) of the participants. Intraoperative complications were encountered in four patients and these included: rectal injuries (n = 2), hemorrhage that required blood transfusion (n = 1), and urinary bladder injury (n = 1). The main postoperative complication was vaginal cuff infection which occurred in 10 (8.3%) of the participants.
Table 3
Surgical procedures performed among the study participants and complications
Surgical procedures n = 120
n (%)
Vaginal hysterectomy with sacrospinous ligament vault fixation
66 (55)
Vaginal hysterectomy plus anterior and posterior repair with uterosacral ligament vault fixation
17 (14.2)
Posterior colporrhaphy only
15 (12.5)
Anterior colporrhaphy only
13 (10.8)
Bilateral sacrospinous vault fixation for vaginal vault prolapse
3 (2.5)
Anterior and Posterior Colporrhaphy combined
3 (2.5)
Sacrospinous Cervicopexy
3 (2.5)
Intraoperative complications
4 (3.3)
Postoperative complications
10 (8.3)
The baseline mean QOL overall and in the specific life domains is shown in Table 4. The participants presenting with POP had a poor QOL with a mean score at baseline of 45.5% (95% CI; 41.7–49.3%). High mean QOL scores were found in the physical, social, emotional, sexual and sleep domains ranging from 40.4 to 61.9%. Personal hygiene and urinary bladder function had the lowest mean QOL scores of 19.9% (95% CI; 15.1–24.8%) and 13.6% (95% CI; 10.1–17.2%) respectively.
Table 4
Baseline mean QOL scores compared to mean QOL scores at 1 year after surgery for POP
Quality of life domains
Baseline
One-year post-surgery
Mean %(95%CI)
Mean% (95%CI)
P value
Overall
45.5 (41.7–49.3)
6.6 (4.5–8.8)
 < 0.001
Physical
66.7 (60.0–73.3)
11.6 (8.1–15.2)
 < 0.001
Social
61.9 (55.6–68.1)
9.0 (5.9–12.1)
 < 0.001
Emotional
58.4 (52.3–64.6)
5.6 (2.6–8.5)
 < 0.001
Sexual
69.1 (61.0–77.3)
13.5 (8.2–18.9)
 < 0.001
Sleep
40.4 (34.6–46.2)
4.9 (1.7–8.1)
 < 0.001
Hygiene
19.9 (15.1–24.8)
0.5 (0.3–1.7)
 < 0.001
Bladder function
13.6 (10.1–17.2)
4.6 (2.7–6.5)
 < 0.001
There was a significant improvement in the overall quality of life as well as in the different domains 1 year after surgery for symptomatic POP as shown in Table 4. The overall mean QOL score at baseline of 45.5% decreased by 38.9–6.6% at 1 year after surgery and this change was statistically significant (p < 0.001). There was also a decrease in all the specific QOL domains at 1 year after surgery for POP. Physical activity domain decreased by 55.1% from 66.7 to 6.6%, social interaction decreased by 52.9% from 61.9 to 9%, emotional status reduced by 52.8% from 58.4 to 5.6%, sexual performance by 55.6% from 69.1 to 13.5% and sleep quality also decreased by 35.5% from 40.4 to 4.9%. Though low at baseline, the mean scores for personal hygiene and urinary bladder function also decreased at 1 year post-surgery by 19.4 and 9% respectively. All these changes were statistically significant (p < 0.001).

Discussion

This study showed that women presenting with symptomatic POP had a poor quality of life before surgery with an overall mean QOL score of 45.5%; surgical management for the symptomatic POP significantly improved the QOL by 38.9%.
The poor QOL in this study is similar to findings from studies done in China and rural Pakistan [35, 36]. This is probably because POP is a complex condition which affects both physical and functional aspects of a woman including physical, social, emotional, sleep, and sexual performance ultimately leading to poor QOL [5].
The poor physical performance observed in this study was also reported in studies done in other low income countries [10, 11, 37]. A study done in South Africa by Brandt et al. 2019 suggested that the poor physical performance in women with POP could be due to chronic pelvic pain caused by stretching and weakening of the pelvic ligaments which makes it difficult for these women to walk, bend and work. Women with POP in our study also had a poor social life score. This is similar to what was observed in studies done in Nepal and Ethiopia [12, 37, 38]. This could be due to the fact that advanced stages of POP (III and IV) are associated with foul smelling vaginal discharge and urinary incontinence which limits the interaction with the community for fear of being discriminated [39]. The poor QOL score among women with POP in the emotional domain was similar to what was found in a study done in USA [16]. This low emotional state in women with POP could be due to a combination of perceived decreased body image, shame, and non-disclosure for fear of discrimination or even divorce in these women [12, 40]. Among the women who were still sexually active, the score in their sexual life was poor and this is similar to what was reported in other studies [5, 7, 1214]. Women with advanced POP are likely to experience dyspareunia, lack of libido and arousal ultimately leading to poor sexual performance [7, 12]. The participants also had poor QOL score in the sleep domain as was found elsewhere [16]. The poor sleep quality may be attributed to the frequent nocturia that is common in women with symptomatic POP [41]. Additionally, the loss of sleep could be as a result of depression in these women [16].
One year following surgery, the overall quality of life including physical, social, emotional, sleep and sexual performance improved. This is similar to what was observed in studies done in the high and low income countries where surgery significantly improved all aspects of women’s life [5, 7, 13, 14, 37, 38, 41]. Bilateral sacrospinous ligament vault suspension which was performed for participants with recurrent vaginal vault prolapse in this study has been shown to improve QOL [42, 43]. Surgery may have improved the overall QOL of life because it relieves patients’ symptoms, restores normal anatomy and function of the pelvic structures [44].
The improvement in physical performance after surgery is similar to that observed in a study from Ethiopia [38]. This improvement could be due to the correction of the anatomical defect leading to a reduction in the chronic pain and discomfort which enables the women to walk and even work comfortably [37]. The social life of the women similarly improved probably because POP surgery has been found to correct associated urinary incontinence [45] which ultimately takes away the bad urine smell resulting in improvement in the social domain [37, 46]. The QOL in the emotional domain improved after surgery similar to that reported in a previous study among American women [41]. The improvement may be because the women did not have any more worries about their body image perception and fear about discrimination from society after surgery [41, 47]. The sleep domain improved after surgery as in a study by Ghetti et al. [41]. This improvement is probably because of the improvement in bladder symptoms such as nocturia as well as improvement in depressive symptoms which occurs after surgery [41, 45, 48, 49]. As was reported in other studies from the developed world [5, 7, 50], sexual function improved after surgery. This is probably because the restoration of the normal vaginal length after surgery leads to a reduction in the dyspareunia that used to be experienced by these women [12, 13, 47]. Additionally, this improvement could be due to a related improvement in the emotional status [16]. Therefore, in addition to surgery, women with symptomatic POP would benefit from a multidisciplinary approach for accurate management [9, 51]. These women should be offered psychosocial support and counselling because they have emotional, social and sexual problems.
Our study has some limitations. This study was conducted at a single regional referral hospital in southwestern Uganda and the findings may not be generalizable to all other women in Uganda. The King’s Health Questionnaire was validated to assess the QOL among women with urinary incontinence but we used it to assess QOL among women with POP in our study since a significant number of women with POP also have urinary incontinence.

Conclusions

Quality of life among women with POP was poor overall and surgery greatly improved women’s quality of life. Surgery, as an option for the management of POP, should be scaled up to improve the QOL among women with symptomatic POP. In addition, women with symptomatic POP should be offered psychosocial support and counselling because they have emotional, social and sexual problems.

Acknowledgements

The authors are grateful to the study participants, staff in the operating theatre, anesthesia department plus obstetrics and gynecology ward of Mbarara Regional Referral Hospital for the assistance given during the study.

Declarations

Ethical approvals were obtained from the Mbarara University of science and Technology (MUST) Research Ethics committee and the Uganda National Council of Science and Technology (UNCST) number HS368ES. Written informed consent was obtained from all the study participants or from their legally authorized representatives for those who couldn’t read or write. All the experiment protocol for involving humans was in accordance to guidelines of national/ international/ institutional or declaration of Helsinki.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(2):165–94.PubMedCrossRef Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(2):165–94.PubMedCrossRef
2.
Zurück zum Zitat Obstetricians ACo, Gynecologists. Pelvic Organ Prolapse: ACOG Practice Bulletin, Number 214. Obstet Gynecol. 2019;134(5):e126–e42. Obstetricians ACo, Gynecologists. Pelvic Organ Prolapse: ACOG Practice Bulletin, Number 214. Obstet Gynecol. 2019;134(5):e126–e42.
3.
Zurück zum Zitat Samuelsson EC, Victor FA, Tibblin G, Svärdsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999;180(2):299–305.PubMedCrossRef Samuelsson EC, Victor FA, Tibblin G, Svärdsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999;180(2):299–305.PubMedCrossRef
4.
Zurück zum Zitat Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11):1559–73.PubMedPubMedCentralCrossRef Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11):1559–73.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Vitale SG, Lagana AS, Gulino FA, Tropea A, Tarda S. Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates Surg. 2016;68(4):325–9.PubMedCrossRef Vitale SG, Lagana AS, Gulino FA, Tropea A, Tarda S. Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates Surg. 2016;68(4):325–9.PubMedCrossRef
7.
Zurück zum Zitat Caruso S, Bandiera S, Cavallaro A, Cianci S, Vitale SG, Rugolo S. Quality of life and sexual changes after double transobturator tension-free approach to treat severe cystocele. Eur J Obstet Gynecol Reprod Biol. 2010;151(1):106–9.PubMedCrossRef Caruso S, Bandiera S, Cavallaro A, Cianci S, Vitale SG, Rugolo S. Quality of life and sexual changes after double transobturator tension-free approach to treat severe cystocele. Eur J Obstet Gynecol Reprod Biol. 2010;151(1):106–9.PubMedCrossRef
8.
Zurück zum Zitat Doaee M, Moradi-Lakeh M, Nourmohammadi A, Razavi-Ratki SK, Nojomi M. Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis. Int Urogynecol J. 2014;25(2):153–63.PubMedCrossRef Doaee M, Moradi-Lakeh M, Nourmohammadi A, Razavi-Ratki SK, Nojomi M. Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis. Int Urogynecol J. 2014;25(2):153–63.PubMedCrossRef
9.
Zurück zum Zitat Laganà AS, La Rosa VL, Rapisarda AMC, Vitale SG. Pelvic organ prolapse: the impact on quality of life and psychological well-being. J Psychosom Obstet Gynecol. 2018;39(2):164–6.CrossRef Laganà AS, La Rosa VL, Rapisarda AMC, Vitale SG. Pelvic organ prolapse: the impact on quality of life and psychological well-being. J Psychosom Obstet Gynecol. 2018;39(2):164–6.CrossRef
10.
Zurück zum Zitat Brandt C, van Vuuren ECJ. Dysfunction, activity limitations, participation restriction and contextual factors in South African women with pelvic organ prolapse. S Afr J Physiother. 2019;75(1):933.PubMedPubMedCentralCrossRef Brandt C, van Vuuren ECJ. Dysfunction, activity limitations, participation restriction and contextual factors in South African women with pelvic organ prolapse. S Afr J Physiother. 2019;75(1):933.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity tosymptoms and quality of life. BJOG Int J Obstet Gynaecol. 2005;112(7):971–6.CrossRef Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity tosymptoms and quality of life. BJOG Int J Obstet Gynaecol. 2005;112(7):971–6.CrossRef
12.
Zurück zum Zitat Bonetti TR, Erpelding A, Pathak LR. Listening to “felt needs”: investigating genital prolapse in western Nepal. Reprod Health Matters. 2004;12(23):166–75.PubMedCrossRef Bonetti TR, Erpelding A, Pathak LR. Listening to “felt needs”: investigating genital prolapse in western Nepal. Reprod Health Matters. 2004;12(23):166–75.PubMedCrossRef
13.
Zurück zum Zitat Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, et al. Quality of life and sexual function 2 years after vaginal surgery for prolapse. Obstet Gynecol. 2016;127(6):1071.PubMedPubMedCentralCrossRef Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, et al. Quality of life and sexual function 2 years after vaginal surgery for prolapse. Obstet Gynecol. 2016;127(6):1071.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Ulrich D, Dwyer P, Rosamilia A, Lim Y, Lee J. The effect of vaginal pelvic organ prolapse surgery on sexual function. Neurourol Urodyn. 2015;34(4):316–21.PubMedCrossRef Ulrich D, Dwyer P, Rosamilia A, Lim Y, Lee J. The effect of vaginal pelvic organ prolapse surgery on sexual function. Neurourol Urodyn. 2015;34(4):316–21.PubMedCrossRef
15.
Zurück zum Zitat Cheung RY, Lee JH, Lee L, Chung TK, Chan SS. Vaginal pessary in women with symptomatic pelvic organ prolapse. Obstet Gynecol. 2016;128(1):73–80.PubMedCrossRef Cheung RY, Lee JH, Lee L, Chung TK, Chan SS. Vaginal pessary in women with symptomatic pelvic organ prolapse. Obstet Gynecol. 2016;128(1):73–80.PubMedCrossRef
16.
Zurück zum Zitat Ghetti C, Skoczylas LC, Oliphant SS, Nikolajski C, Lowder JL. The emotional burden of pelvic organ prolapse in women seeking treatment: a qualitative study. Female Pelvic Med Reconstr Surg. 2015;21(6):332.PubMedPubMedCentralCrossRef Ghetti C, Skoczylas LC, Oliphant SS, Nikolajski C, Lowder JL. The emotional burden of pelvic organ prolapse in women seeking treatment: a qualitative study. Female Pelvic Med Reconstr Surg. 2015;21(6):332.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Gjerde JL, Rortveit G, Muleta M, Adefris M, Blystad A. Living with pelvic organ prolapse: voices of women from Amhara region. Ethiop Int Urogynecol J. 2017;28(3):361–6.CrossRef Gjerde JL, Rortveit G, Muleta M, Adefris M, Blystad A. Living with pelvic organ prolapse: voices of women from Amhara region. Ethiop Int Urogynecol J. 2017;28(3):361–6.CrossRef
18.
Zurück zum Zitat Krause HG, Hall BA, Ng S-K, Natukunda H, Singasi I, Goh JT. Mental health screening in women with severe pelvic organ prolapse, chronic fourth-degree obstetric tear and genital tract fistula in western Uganda. Int Urogynecol J. 2017;28(6):893–7.PubMedCrossRef Krause HG, Hall BA, Ng S-K, Natukunda H, Singasi I, Goh JT. Mental health screening in women with severe pelvic organ prolapse, chronic fourth-degree obstetric tear and genital tract fistula in western Uganda. Int Urogynecol J. 2017;28(6):893–7.PubMedCrossRef
19.
Zurück zum Zitat Barros CR, Machado RB, de Camargo ACM, Gollop TR. Tratamento conservador de prolapso de órgão pélvico com pessário: revisão de literatura. Revista de Medicina. 2018;97(2):154–9.CrossRef Barros CR, Machado RB, de Camargo ACM, Gollop TR. Tratamento conservador de prolapso de órgão pélvico com pessário: revisão de literatura. Revista de Medicina. 2018;97(2):154–9.CrossRef
20.
Zurück zum Zitat Powers K, Lazarou G, Wang A, LaCombe J, Bensinger G, Greston WM, et al. Pessary use in advanced pelvic organ prolapse. Int Urogynecol J. 2006;17(2):160–4.CrossRef Powers K, Lazarou G, Wang A, LaCombe J, Bensinger G, Greston WM, et al. Pessary use in advanced pelvic organ prolapse. Int Urogynecol J. 2006;17(2):160–4.CrossRef
21.
Zurück zum Zitat Goh TWJ, Thayalan K, Krause HG. An audit of vaginal support pessaries for pelvic organ prolapse in western Uganda. Aust N Zeal Cont J. 2020;26(2):46. Goh TWJ, Thayalan K, Krause HG. An audit of vaginal support pessaries for pelvic organ prolapse in western Uganda. Aust N Zeal Cont J. 2020;26(2):46.
22.
Zurück zum Zitat Abdool Z. Evaluation of vaginal pessary use by South African gynaecologists. S Afr J Obstet Gynaecol. 2011;17(3):64–7. Abdool Z. Evaluation of vaginal pessary use by South African gynaecologists. S Afr J Obstet Gynaecol. 2011;17(3):64–7.
23.
24.
Zurück zum Zitat Jones KA, Shepherd JP, Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in inpatient prolapse procedures in the United States, 1979–2006. Am J Obstet Gynecology. 2010;202(5):501.CrossRef Jones KA, Shepherd JP, Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in inpatient prolapse procedures in the United States, 1979–2006. Am J Obstet Gynecology. 2010;202(5):501.CrossRef
25.
Zurück zum Zitat Krause HG, Natukunda H, Singasi I, Hicks SS, Goh JT. Treatment-seeking behaviour and social status of women with pelvic organ prolapse, 4th-degree obstetric tears, and obstetric fistula in western Uganda. Int Urogynecol J. 2014;25(11):1555–9.PubMedCrossRef Krause HG, Natukunda H, Singasi I, Hicks SS, Goh JT. Treatment-seeking behaviour and social status of women with pelvic organ prolapse, 4th-degree obstetric tears, and obstetric fistula in western Uganda. Int Urogynecol J. 2014;25(11):1555–9.PubMedCrossRef
26.
Zurück zum Zitat Katsara A, Wight E, Heinzelmann-Schwarz V, Kavvadias T. Long-term quality of life, satisfaction, pelvic floor symptoms and regret after colpocleisis. Arch Gynecol Obstet. 2016;294(5):999–1003.PubMedCrossRef Katsara A, Wight E, Heinzelmann-Schwarz V, Kavvadias T. Long-term quality of life, satisfaction, pelvic floor symptoms and regret after colpocleisis. Arch Gynecol Obstet. 2016;294(5):999–1003.PubMedCrossRef
27.
Zurück zum Zitat Tyagi V, Perera M, Guerrero K, Hagen S, Pringle S. Prospective observational study of the impact of vaginal surgery (pelvic organ prolapse with or without urinary incontinence) on female sexual function. Int Urogynecol J. 2018;29(6):837–45.PubMedCrossRef Tyagi V, Perera M, Guerrero K, Hagen S, Pringle S. Prospective observational study of the impact of vaginal surgery (pelvic organ prolapse with or without urinary incontinence) on female sexual function. Int Urogynecol J. 2018;29(6):837–45.PubMedCrossRef
28.
Zurück zum Zitat Mattsson NK, Karjalainen PK, Tolppanen A-M, Heikkinen A-M, Sintonen H, Härkki P, et al. Pelvic organ prolapse surgery and quality of life—a nationwide cohort study. Am J Obstet Gynecol. 2020;222(6):588.PubMedCrossRef Mattsson NK, Karjalainen PK, Tolppanen A-M, Heikkinen A-M, Sintonen H, Härkki P, et al. Pelvic organ prolapse surgery and quality of life—a nationwide cohort study. Am J Obstet Gynecol. 2020;222(6):588.PubMedCrossRef
29.
Zurück zum Zitat Persu C, Chapple C, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP–Q): a new era in pelvic prolapse staging. J Med Life. 2011;4(1):75.PubMedPubMedCentral Persu C, Chapple C, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP–Q): a new era in pelvic prolapse staging. J Med Life. 2011;4(1):75.PubMedPubMedCentral
30.
Zurück zum Zitat Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.PubMedCrossRef Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.PubMedCrossRef
31.
Zurück zum Zitat Kelleher C, Cardozo L, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. BJOG Int J Obstet Gynaecol. 1997;104(12):1374–9.CrossRef Kelleher C, Cardozo L, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. BJOG Int J Obstet Gynaecol. 1997;104(12):1374–9.CrossRef
32.
Zurück zum Zitat Bai S, Jeon MJ, Kim J, Chung K, Kim S, Park K. Relationship between stress urinary incontinence and pelvic organ prolapse. Int Urogynecol J. 2002;13(4):256–60.CrossRef Bai S, Jeon MJ, Kim J, Chung K, Kim S, Park K. Relationship between stress urinary incontinence and pelvic organ prolapse. Int Urogynecol J. 2002;13(4):256–60.CrossRef
33.
Zurück zum Zitat Muñiz KS, Pilkinton M, Winkler HA, Shalom DF. Prevalence of stress urinary incontinence and intrinsic sphincter deficiency in patients with stage IV pelvic organ prolapse. J Obstet Gynaecol Res. 2021;47(2):640–4.PubMedCrossRef Muñiz KS, Pilkinton M, Winkler HA, Shalom DF. Prevalence of stress urinary incontinence and intrinsic sphincter deficiency in patients with stage IV pelvic organ prolapse. J Obstet Gynaecol Res. 2021;47(2):640–4.PubMedCrossRef
34.
Zurück zum Zitat Putra I, Megadhana I, Suwiyoga K, Junizaf H, Santoso B. Prevalence of urinary incontinence in women with pelvic organ prolapse at Sanglah hospital Denpasar, Bali-Indonesia. Bali Med J. 2016;5(1):125–8.CrossRef Putra I, Megadhana I, Suwiyoga K, Junizaf H, Santoso B. Prevalence of urinary incontinence in women with pelvic organ prolapse at Sanglah hospital Denpasar, Bali-Indonesia. Bali Med J. 2016;5(1):125–8.CrossRef
35.
Zurück zum Zitat Chan SSC, Cheung RYK, Yiu KW, Lee LL, Pang AWL, Chung TKH. Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse. Int Urogynecol J. 2012;23(8):1027–33.PubMedCrossRef Chan SSC, Cheung RYK, Yiu KW, Lee LL, Pang AWL, Chung TKH. Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse. Int Urogynecol J. 2012;23(8):1027–33.PubMedCrossRef
36.
Zurück zum Zitat Jokhio AH, Rizvi RM, MacArthur C. Prevalence of pelvic organ prolapse in women, associated factors and impact on quality of life in rural Pakistan: population-based study. BMC Womens Health. 2020;20:1–7.CrossRef Jokhio AH, Rizvi RM, MacArthur C. Prevalence of pelvic organ prolapse in women, associated factors and impact on quality of life in rural Pakistan: population-based study. BMC Womens Health. 2020;20:1–7.CrossRef
37.
Zurück zum Zitat Dhital R, Otsuka K, Poudel KC, Yasuoka J, Dangal G, Jimba M. Improved quality of life after surgery for pelvic organ prolapse in Nepalese women. BMC Womens Health. 2013;13(1):22.PubMedPubMedCentralCrossRef Dhital R, Otsuka K, Poudel KC, Yasuoka J, Dangal G, Jimba M. Improved quality of life after surgery for pelvic organ prolapse in Nepalese women. BMC Womens Health. 2013;13(1):22.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Gjerde JL, Ayele TA. Pelvic organ prolapse surgery and health-related quality of life: a follow-up study. BMC Womens Health. 2021;21(1):1–11.CrossRef Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Gjerde JL, Ayele TA. Pelvic organ prolapse surgery and health-related quality of life: a follow-up study. BMC Womens Health. 2021;21(1):1–11.CrossRef
39.
Zurück zum Zitat Shrestha A, Lakhey B, Sharma J, Singh M, Shrestha B, Singh S. Prevalence of uterine prolapse amongst gynecology OPD patients in Tribhuwan university teaching hospital in Nepal and its socio-cultural determinants. Res Cent Women. The Asian-Pacific Resource & Research Center for Women (ARROW), Kuala Lumpur, Malaysia; 2009. Shrestha A, Lakhey B, Sharma J, Singh M, Shrestha B, Singh S. Prevalence of uterine prolapse amongst gynecology OPD patients in Tribhuwan university teaching hospital in Nepal and its socio-cultural determinants. Res Cent Women. The Asian-Pacific Resource & Research Center for Women (ARROW), Kuala Lumpur, Malaysia; 2009.
40.
Zurück zum Zitat Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006;194(5):1455–61.PubMedCrossRef Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006;194(5):1455–61.PubMedCrossRef
41.
Zurück zum Zitat Ghetti C, Lowder JL, Ellison R, Krohn M, Moalli P. Depressive symptoms in women seeking surgery for pelvic organ prolapse. Int Urogynecol J. 2010;21(7):855–60.PubMedPubMedCentralCrossRef Ghetti C, Lowder JL, Ellison R, Krohn M, Moalli P. Depressive symptoms in women seeking surgery for pelvic organ prolapse. Int Urogynecol J. 2010;21(7):855–60.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Coolen A-LW, Bui BN, Dietz V, Wang R, van Montfoort AP, Mol BWJ, et al. The treatment of post-hysterectomy vaginal vault prolapse: a systematic review and meta-analysis. Int Urogynecol J. 2017;28(12):1767–83.PubMedPubMedCentralCrossRef Coolen A-LW, Bui BN, Dietz V, Wang R, van Montfoort AP, Mol BWJ, et al. The treatment of post-hysterectomy vaginal vault prolapse: a systematic review and meta-analysis. Int Urogynecol J. 2017;28(12):1767–83.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Vitale SG, Laganà AS, Noventa M, Giampaolino P, Zizolfi B, Butticè S, et al. Transvaginal bilateral sacrospinous fixation after second recurrence of vaginal vault prolapse: efficacy and impact on quality of life and sexuality. BioMed Res Int. 2018;2018:5727165.PubMedPubMedCentralCrossRef Vitale SG, Laganà AS, Noventa M, Giampaolino P, Zizolfi B, Butticè S, et al. Transvaginal bilateral sacrospinous fixation after second recurrence of vaginal vault prolapse: efficacy and impact on quality of life and sexuality. BioMed Res Int. 2018;2018:5727165.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Ellington DR, Richter HE. The role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk. Obstet Gynecol Int. 2013;2013:356960.PubMedPubMedCentralCrossRef Ellington DR, Richter HE. The role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk. Obstet Gynecol Int. 2013;2013:356960.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat de Boer TA, Kluivers KB, Withagen MI, Milani AL, Vierhout ME. Predictive factors for overactive bladder symptoms after pelvic organ prolapse surgery. Int Urogynecol J. 2010;21(9):1143–9.PubMedPubMedCentralCrossRef de Boer TA, Kluivers KB, Withagen MI, Milani AL, Vierhout ME. Predictive factors for overactive bladder symptoms after pelvic organ prolapse surgery. Int Urogynecol J. 2010;21(9):1143–9.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Gjerde JL, Rortveit G, Adefris M, Belayneh T, Blystad A. Life after pelvic organ prolapse surgery: a qualitative study in Amhara region, Ethiopia. BMC Womens Health. 2018;18(1):74.PubMedPubMedCentralCrossRef Gjerde JL, Rortveit G, Adefris M, Belayneh T, Blystad A. Life after pelvic organ prolapse surgery: a qualitative study in Amhara region, Ethiopia. BMC Womens Health. 2018;18(1):74.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Lowder JL, Ghetti C, Moalli P, Zyczynski H, Cash TF. Body image in women before and after reconstructive surgery for pelvic organ prolapse. Int Urogynecol J. 2010;21(8):919–25.PubMedCrossRef Lowder JL, Ghetti C, Moalli P, Zyczynski H, Cash TF. Body image in women before and after reconstructive surgery for pelvic organ prolapse. Int Urogynecol J. 2010;21(8):919–25.PubMedCrossRef
48.
Zurück zum Zitat Himmler M, Rakhimbayeva A, Sutherland SE, Roovers J-P, Yassouridis A, Liedl B. The impact of sacrospinous ligament fixation on pre-existing nocturia and co-existing pelvic floor dysfunction symptoms. Int Urogynecol J. 2020;32(4):919–28.PubMedPubMedCentralCrossRef Himmler M, Rakhimbayeva A, Sutherland SE, Roovers J-P, Yassouridis A, Liedl B. The impact of sacrospinous ligament fixation on pre-existing nocturia and co-existing pelvic floor dysfunction symptoms. Int Urogynecol J. 2020;32(4):919–28.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Kim MS, Lee GH, Na ED, Jang JH, Kim HC. The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse. Obstet Gynecol Sci. 2016;59(3):214–9.PubMedPubMedCentralCrossRef Kim MS, Lee GH, Na ED, Jang JH, Kim HC. The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse. Obstet Gynecol Sci. 2016;59(3):214–9.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Farthmann J, Mengel M, Henne B, Grebe M, Watermann D, Kaufhold J, et al. Improvement of pelvic floor-related quality of life and sexual function after vaginal mesh implantation for cystocele: primary endpoint of a prospective multicentre trial. Arch Gynecol Obstet. 2016;294(1):115–21.PubMedCrossRef Farthmann J, Mengel M, Henne B, Grebe M, Watermann D, Kaufhold J, et al. Improvement of pelvic floor-related quality of life and sexual function after vaginal mesh implantation for cystocele: primary endpoint of a prospective multicentre trial. Arch Gynecol Obstet. 2016;294(1):115–21.PubMedCrossRef
51.
Zurück zum Zitat Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS. The importance of a multidisciplinary approach for women with pelvic organ prolapse and cystocele. Oman Med J. 2017;100(5513):1–2. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS. The importance of a multidisciplinary approach for women with pelvic organ prolapse and cystocele. Oman Med J. 2017;100(5513):1–2.
Metadaten
Titel
Impact of surgery on quality of life of Ugandan women with symptomatic pelvic organ prolapse: a prospective cohort study
verfasst von
Musa Kayondo
Dan Kabonge Kaye
Richard Migisha
Rodgers Tugume
Paul Kalyebara Kato
Henry Mark Lugobe
Verena Geissbüehler
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Women's Health / Ausgabe 1/2021
Elektronische ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01397-z

Weitere Artikel der Ausgabe 1/2021

BMC Women's Health 1/2021 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.